Ariad Pharmaceuticals Inc fka ARIA

[grandma_of_jbraika]

Dr. Cortes: New Trials 30mg Pona + Aspirin/Statin:

ASH 2013: CML - Novel agents and new trials, published on Dec 12, 2013

Sb. posted at 5:00 am on Nov. 12: Ariad will partner Iclusig and restart an EPIC-like trial with 30 mg dose + a statin/Aspiprin

Hours later, Dr. Berger said "We don't not rule out the front line" at the 3Q CC and he said another medication preventing clots may be as simple as an Aspirin.

"It really depends on the dose and the data we collect in the front line. Clearly, we need to run trials at lower doses. We don't rule out the front line. But it would have to be based upon data, not just hypothesis."

Is the YMB poster Dr. Cortes or Dr. Berger? LOL!